BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $4.1 million in its second quarter.

On a per-share basis, the Beverly Hills, California-based company said it had a loss of 14 cents.

The biotechnology company posted revenue of $404,000 in the period.

In the final minutes of trading on Thursday, the company's shares hit $1.20. A year ago, they were trading at $1.13.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR